Pharmaceutical - Publications - Faculty & Research

25 Oct 2004
Research & Ideas

Planning for Surprises

just two suppliers, while Great Britain has five suppliers to reduce the risk of supply disruptions. While fear of lawsuits has played a role, the fundamental problem is that the economics of vaccine production are unattractive for View Details

Keywords: by Martha Lagace

09 Feb 2004
Research & Ideas

Got a New Strategy? Now Make it Happen

It does so by fitting the organization to the strategy and increasing fitness, the capacity of the organization to learn and change. Since then, this process has been used in more than 150 businesses in the retail, hospitality, high technology, banking, and View Details

Keywords: by Michael Beer & Russell A. Eisenstat

July 2017 (Revised July 2019)
Supplement

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)

By: Nori Gerardo Lietz and Ricardo Andrade

The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details

Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

Citation

July 2016 (Revised July 2019)
Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade

In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details

Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

Citation

Purchase

April 2016 (Revised July 2019)
Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz

In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details

Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

Citation

Educators

August 2003
Teaching Note

Pharmacyclics: Financing Research and Development (TN)

By: Malcolm P. Baker and Richard S. Ruback

Teaching Note for (9-201-056). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

Citation

Purchase

24 Sep 2013
First Look

First Look: September 24

models a negotiation between two pharmaceutical companies-Johnson & Johnson and Merck-concerning the international distribution rights for Remicade, a blockbuster anti-arthritis drug. At odds over the original distribution contract,... View Details

Keywords: Sean Silverthorne

26 Apr 2023
Cold Call Podcast

How Martine Rothblatt Started a Company to Save Her Daughter

Keywords: Re: Debora L. Spar; Pharmaceutical; Pharmaceutical; Pharmaceutical

Research Summary

Overview

I am interested in the individual experience of learning in organizational settings, particularly how employees learn to learn from the challenging work they do. I am currently researching the role of reflection for raising awareness of learning opportunities that... View Details

Keywords: Learning; Learning And Development; Learning Organizations; Intrinsic Motivation; Reflection; Goal Setting; Performance Measurement; Innovation; Job Design; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

January 2023
Teaching Note

The Opioid Settlement and Executive Pay at AmerisourceBergen

By: Suraj Srinivasan and Li-Kuan Ni

Teaching Note for HBS Case No 122-014. In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged... View Details

Citation

Purchase

Article

Internal Deadlines, Drug Approvals, and Safety Problems

By: Lauren Cohen, Umit Gurun and Danielle Li

Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details

Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

Citation

SSRN

Find at Harvard

February 1999
Teaching Note

Wegmans Food Markets: Diabetes Counseling TN

By: David E. Bell

Teaching Note for (9-599-057). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

Citation

Purchase

02 Jul 2001
Research & Ideas

Ray A. Goldberg

is the blurring of agriculture and pharmaceuticals limited to seeds and plants. Animals are being turned into drug-manufacturing facilities" as well. Thus, Goldberg says, bioengineering may some day lead to animals whose milk, for... View Details

Keywords: by Staff; Agriculture & Agribusiness

14 Dec 2010
First Look

First Look: Dec. 14

addresses a decision to replace salesmen netbook PCs with iPhones, including converting the company's sales and customer applications to the iPhone platform. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/911413-PDF-ENG Hikma View Details

Keywords: Sean Silverthorne

16 Oct 2007
First Look

First Look: October 16, 2007

this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=508036 Michael Fernandes at Nicholas Piramal Harvard Business School Case 408-001 Michael Fernandes, the Director of Custom Manufacturing Operations at the View Details

Keywords: Sean Silverthorne

15 Feb 2000
Research & Ideas

The Right Connections

pharmaceutical companies — what the authors call downstream social capital — had a direct impact on the size of the startup's IPO. "Downstream social capital was essential in attracting the interest of a top investment bank and... View Details

Keywords: by Judith A. Ross

19 Dec 2005
Research & Ideas

The Regional Slice of Your Global Strategy

equipment, and pharmaceuticals have invested significantly in modern mapping technology, using such innovations as enhanced clustering techniques, better measures for analyzing networks, and expanded data on bilateral, multilateral, and... View Details

Keywords: by Pankaj Ghemawat

July 1981 (Revised December 1984)
Case

American Distilling Co. (A)

By: William E. Fruhan Jr.

Keywords: Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

Citation

Find at Harvard

June 2010 (Revised February 2013)
Background Note

The Precautionary Principle

By: Michael W. Toffel and Nazli Z. Uludere Aragon

This note describes the precautionary principle and its key tenets, highlights challenges associated with its use, and includes many examples of its application, primarily within the realm of regulating activities based on the risk of harm to human health and the... View Details

Keywords: Governing Rules, Regulations, and Reforms; Policy; Health Disorders; Business and Government Relations; Safety; Natural Environment; Pollutants; Agriculture and Agribusiness Industry; Chemical Industry; Pharmaceutical Industry

Citation

Educators

Purchase

September 2019
Case

Dementia Discovery Fund

By: Richard G. Hamermesh, Kathy Giusti and Sarah Gulick

The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged... View Details